S&P 500 7,702 -0.60% Nasdaq 26,197 -1.47% Dow Jones 53,474 -0.55% FTSE 100 10,726 -0.99% DAX 26,114 -0.82% Nikkei 225 65,326 -4.37% Hang Seng 25,495 +0.22% WTI Crude 84.36 +2.38% Gold 4,517 +3.13% US 10-Year Treasury Yield 4.653 +0.26% S&P 500 7,702 -0.60% Nasdaq 26,197 -1.47% Dow Jones 53,474 -0.55% FTSE 100 10,726 -0.99% DAX 26,114 -0.82% Nikkei 225 65,326 -4.37% Hang Seng 25,495 +0.22% WTI Crude 84.36 +2.38% Gold 4,517 +3.13% US 10-Year Treasury Yield 4.653 +0.26%

LATEST

Chinese InsurTech Firm Zhibao Adds 2,380 Bitcoin in $154.7M Treasury Pivot●Shanghai lays out plan to boost digital economy, catch up with Beijing, Shenzhen●Trump Dangles Keystone XL Revival as Canada Tariff Deadline Looms●200,000 fake AI ‘victims’ deployed to scam bait online fraudsters●SEC regulatory proposal marks ‘important’ step forward from ‘inapt’ crypto rules: Commissioner Peirce●Deoleo, the world's largest olive oil company, stock surges as Spanish cooperative Dcoop leads takeover race●Deoleo stock surges as Dcoop leads €470 million takeover bid●Wall Street just borrowed $500 billion to build AI — here's what it could mean for your 401(k). Are you ready?●Chinese InsurTech Firm Zhibao Adds 2,380 Bitcoin in $154.7M Treasury Pivot●Shanghai lays out plan to boost digital economy, catch up with Beijing, Shenzhen●Trump Dangles Keystone XL Revival as Canada Tariff Deadline Looms●200,000 fake AI ‘victims’ deployed to scam bait online fraudsters●SEC regulatory proposal marks ‘important’ step forward from ‘inapt’ crypto rules: Commissioner Peirce●Deoleo, the world's largest olive oil company, stock surges as Spanish cooperative Dcoop leads takeover race●Deoleo stock surges as Dcoop leads €470 million takeover bid●Wall Street just borrowed $500 billion to build AI — here's what it could mean for your 401(k). Are you ready?●

Wealth

Moderna’s stock doubles on promising cancer-vaccine results

MarketWatch.com - Top Stories · 1h ago

Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Read the full story at MarketWatch.com - Top Stories →

More Wealth

I’m leaving my grandkids money — but they must pass financial-literacy classes to get it. Is that fair?

MarketWatch.com - Top Stories · 54m ago

Marvell’s stock surges on news of Google chip deal — and Broadcom’s falls

MarketWatch.com - Top Stories · 56m ago

SK Hynix suggests its stock is too cheap as it embarks on $29 billion buyback

MarketWatch.com - Top Stories · 1h ago

Should you Venmo your tuition? Here’s what to know as colleges add new payment options.

MarketWatch.com - Top Stories · 2h ago